CJC-1295 (No DAC) 10mg

---

 

CJC-1295 (No DAC) 10mg – Research Peptide

 

Product Overview

CJC-1295 (without DAC), also known as Modified GRF (1-29), is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). It is commonly utilized in laboratory and preclinical research settings to study pulsatile growth hormone signaling and receptor interaction dynamics.

This peptide is of interest in controlled research environments examining endocrine system signaling, including pathways associated with growth hormone release and regulatory feedback mechanisms.

---

 

Key Research Applications

 

• Investigation of GHRH receptor activity in in vitro models

• Study of pulsatile growth hormone signaling mechanisms

• Analysis of endocrine system feedback loops and hormone regulation

• Research involving peptide-receptor binding and signal transduction pathways

 

---

 

Product Specifications

 

• Contents: Lyophilized CJC-1295 (Modified GRF 1-29, no DAC)

• Purity: ≥98% (typical, batch-dependent)

• Quantity: 10mg per vial

• Sequence: Synthetic analog of GHRH (1-29)

• Storage: Store in a cool, dry environment; refrigerate after reconstitution

 

---

 

Quality & Compliance

 

Each batch is produced using industry-standard peptide synthesis and purification processes. Quality control measures are implemented to verify identity, purity, and consistency. Certificates of Analysis (COAs) may be available upon request for select batches.

---

 

Important Disclaimer

 

This product is intended strictly for laboratory research and educational purposes only.

Not for human or veterinary use.

Not intended to diagnose, treat, cure, or prevent any disease.

All information provided is for informational and research reference purposes only and should not be interpreted as medical advice. NordWellness makes no claims regarding therapeutic use or outcomes.